Zylox-Tonbridge and GL Capital invest US$189M in LifeTech Scientific

Zylox-Tonbridge Medical Technology and GL Capital will jointly invest approximately HK$1.48 billion (US$189 million) in LifeTech Scientific through GL Lighthouse Two Investment. Lighthouse Two will subscribe for newly issued shares representing about 16.7% of LifeTech's enlarged share capital. Separately, GL Capital will acquire 39.8 million newly issued Zylox-Tonbridge shares.

“The investment aims to bring the two medical device manufacturers closer together and establish an integrated platform covering vascular and structural heart interventions.”healthcaremea.com

• 1 source
• healthcaremea.comZylox-Tonbridge explores LifeTech merger after US$189M investment deal in China | HealthCare Middle East & Africa - No.1 Health & Pharma Manufacturing Industry PublicationNov 11, 2026

Summarized from public sources; check the original articles before acting on it.